Intratumoral Administration of High-Concentration Nitric Oxide and Anti PD-1 Treatment Leads to Higher Tumor Regression Rates and Prolonged Survival in CT26 Tumor-Bearing Mice – Society for Immunotherapy of Cancer (SITC) 2022 Annual Meeting
Hila Confino, David Greenberg, Selena Chaisson, Jedd Monson, Steve Lisi, Amir Avniel, Ido Wolf, Yana Epshtein • 11/10/2022